Li L, Li L, Huang Q, Sun J, Yan F, Wei W, et al. Efficacy and safety of osimertinib for patients with EGFR-mutated NSCLC: a systematic review and meta-analysis of randomized controlled studies. AO [Internet]. 2022 Nov. 2 [cited 2026 Jun. 22];61(11):1347-53. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/23840